IHC staining of the subcutaneous tumor tissue formed by HCCLM3 cells revealed that TAS4464 treatment significantly reduced PCNA protein expression and the number of Ki-67-positive cells (Fig. 7H). The gene discussed is PCNA; the disease is neoplasm.